Deep intronic founder mutations identified in the <i>ERCC4</i> / <i>XPF</i> gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum
Chikako Senju(Nagasaki University), Tomoo Ogi(Nagasaki University)
Cited by 12
Related Papers
Hypomorphic PCNA mutation underlies a human DNA repair disorder
|Journal of Clinical Investigation|2014|98
Endogenous aldehyde-induced DNA–protein crosslinks are resolved by transcription-coupled repair
|Nature Cell Biology|2024|56
Expanding the phenotypic spectrum of ARCN1-related syndrome
|Genetics in Medicine|2022|15
TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation–group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy
|Journal of Clinical Investigation|2025|2